Crystal structure of quinone reductase 2 in complex with resveratrol

Biochemistry

Volumn 43, Issue 36, 2004, Pages 11417-11426

  Buryanovskyy, Leonid ^a   Fu, Yue ^a   Boyd, Molly ^a   Ma, Yuliang ^b   Hsieh, Tze Chen ^a   Wu, Joseph M ^a   Zhang, Zhongtao ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISSOCIATION CONSTANTS; ENZYME EXPRESSION; NATURAL POLYPHENOLS; OXIDATIVE STRESSES;

AMINO ACIDS; CELLS; CRYSTAL STRUCTURE; ENZYMES; HYDROGEN BONDS; OXIDATION; TOXICITY;

BIOCHEMISTRY;

3 PHENYLCOUMARIN; AMINO ACID; ANTIOXIDANT; BAICALEIN; CHALCONE; COUMARIN DERIVATIVE; FLAVINE ADENINE NUCLEOTIDE; FLAVONE DERIVATIVE; FLAVONOID; HYDROXYL GROUP; POLYPHENOL; QUERCETIN; QUINONE DERIVATIVE; QUINONE REDUCTASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL; SMALL INTERFERING RNA; STILBENE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DETOXIFICATION; DISSOCIATION CONSTANT; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; HEART PROTECTION; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; KNOCKOUT GENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STRUCTURE ANALYSIS;

BINDING, COMPETITIVE; CRYSTALLOGRAPHY, X-RAY; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; K562 CELLS; PROTEIN BINDING; QUINONE REDUCTASES; RNA INTERFERENCE; STILBENES; TRANSFECTION; VITAMIN K 3;

EID: 4444267291     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049162o     Document Type: Article

References (69)

1. Soleas, G. J., Diamandis, E. P., and Goldberg, D. M. (1997) Wine as a biological fluid: History, production, and role in disease prevention, J. Clin. Lab. Anal. 11, 287-313.
2. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science 275, 218-220.
3. Bhat, K. P., and Pezzuto, J. M. (2002) Cancer chemopreventive activity of resveratrol, Ann. N.Y. Acad. Sci. 957, 210-229.
4. Schneider, Y., Duranton, B., Gosse, F., Schleiffer, R., Seiler, N., and Raul, F. (2001) Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis, Nutr. Cancer 39, 102-107.
5. Corpet, D. E., and Pierre, F. (2003) Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system, Cancer Epidemiol., Biomarkers Prev. 12, 391-400.
6. Cal, C., Garban, H., Jazirehi, A., Yeh, C., Mizutani, Y., and Bonavida, B. (2003) Resveratrol and cancer: Chemoprevention, apoptosis, and chemo-immunosensitizing activities, Curr. Med. Chem. Anti-Cancer Agents 3, 77-93.
7. Cai, Y. J., Fang, J. G., Ma, L. P., Yang, L., and Liu, Z. L. (2003) Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues, Biochim. Biophys. Acta 1637, 31-38.
8. Fan, X., and Matthis, J. P. (2001) Inhibition of oxidative and antioxidative enzymes by trans-resveratrol, J. Food Sci. 66, 200-203.
9. Martinez, J., and Moreno, J. J. (2000) Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production, Biochem. Pharmacol. 59, 865-870.
10. Floreani, M., Napoli, E., Quintieri, L., and Palatini, P. (2003) Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity, Life Sci. 72, 2741-2750.
11. Cao, Z., and Li, Y. (2004) Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: Protection against oxidative and electrophilic injury, Eur. J. Pharmacol. 489, 39-48.
12. Dinkova-Kostova, A. T., and Talalay, P. (2000) Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen, Free Radical Biol. Med. 29, 231-240.
13. Cerutti, P. A. (1994) Oxy-radicals and cancer, Lancet 344, 862-863.
14. Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and Monks, T. J. (2000) Role of quinones in toxicology, Chem. Res. Toxicol. 13, 135-160.
15. Marnett, L. J. (2000) Oxyradicals and DNA damage, Carcinogenesis 21, 361-370.
16. Brooks, J. D., Goldberg, M. F., Nelson, L. A., Wu, D., and Nelson, W. G. (2002) Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro, Cancer Epidemiol., Biomarkers Prev. 11, 868-875.
17. Valerio, L. G., Jr., Kepa, J. K., Pickwell, G. V., and Quattrochi, L. C. (2001) Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin, Toxicol. Lett. 119, 49-57.
18. Jang, D. S., Park, E. J., Hawthorne, M. E., Vigo, J. S., Graham, J. G., Cabieses, F., Santarsiero, B. D., Mesecar, A. D., Fong, H. H., Mehta, R. G., Pezzuto, J. M., and Kinghorn, A. D. (2003) Potential cancer chemopreventive constituents of the seeds of Dipteryx odorata (tonka bean), J. Nat. Prod. 66, 583-587.
19. Zhao, Q., Yang, X. L., Holtzclaw, W. D., and Talalay, P. (1997) Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase), Proc. Natl. Acad. Sci. U.S.A. 94, 1669-1674.
20. Otwinowski, Z., and Minor, W. (1997) in Methods in Enzymology (Carter, J. R. M. S. C. W., Ed.) pp 307-326, Academic Press, New York.
21. Foster, C. E., Bianchet, M. A., Talalay, P., Zhao, Q., and Amzel, L. M. (1999) Crystal structure of human quinone reductase type 2, a metalloflavoprotein, Biochemistry 38, 9881-9886.
22. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography and NMR system: A new software suite for macromolecular structure determination, Acta Crystallogr., Sect. D 54 (Part 5), 905-921.
23. Guex, N., and Peitsch, M. C. (1997) SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling, Electrophoresis 18, 2714-2723.
24. Harris, M., and Jones, T. A. (2001) Molray - A web interface between O and the POV-Ray ray tracer, Acta Crystallogr., Sect. D 57, 1201-1203.
25. Lam, A. M., Keeney, D., and Frick, D. N. (2003) Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action, J. Biol. Chem. 278, 44514-44524.
26. Kuby, S. A. (1991) Enzyme Catalysis, Kinetics, and Substrate Binding, Vol. 1, CRC Press, Boca Raton, FL.
27. Iqbal, M., Sharma, S. D., Okazaki, Y., Fujisawa, M., and Okada, S. (2003) Dietary supplementation of curcumin enhances anti-oxidant and phase II metabolizing enzymes in ddY male mice: Possible role in protection against chemical carcinogenesis and toxicity, Pharmacol. Toxicol. 92, 33-38.
28. Chen, S., Wu, K., Zhang, D., Sherman, M., Knox, R., and Yang, C. S. (1999) Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: Combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling, Mol. Pharmacol. 56, 272-278.
29. Liao, S. W.-A., H. G. (1961) Enzymatic oxidation of some nonphosphorylated derivatives of dihydronicotinamide, Biochem. Biophys. Res. Commun. 4, 208-213.
30. Wu, K., Knox, R., Sun, X. Z., Joseph, P., Jaiswal, A. K., Zhang, D., Deng, P. S., and Chen, S. (1997) Catalytic properties of NAD-(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase, Arch. Biochem. Biophys. 347, 221-228.
31. Bertelli, A. A., Giovannini, L., Stradi, R., Urien, S., Tillement, J. P., and Bertelli, A. (1996) Kinetics of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after red wine oral administration in rats, Int. J. Clin. Pharmacol. Res. 16, 77-81.
32. Li, R., Bianchet, M. A., Talalay, P., and Amzel, L. M. (1995) The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: Mechanism of the two-electron reduction, Proc. Natl. Acad. Sci. U.S.A. 92, 8846-8850.
33. Ross, J. S., Stagliano, N. E., Donovan, M. J., Breitbart, R. E., and Ginsburg, G. S. (2001) Atherosclerosis: A cancer of the blood vessels? Am. J. Clin. Pathol. Suppl. 116 S97-S107.
34. Long, D. J., II, Iskander, K., Gaikwad, A., Arin, M., Roop, D. R., Knox, R., Barrios, R., and Jaiswal, A. K. (2002) Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity, J. Biol. Chem. 277, 46131-46139.
35. Long, D. J., II, Gaikwad, A., Multani, A., Pathak, S., Montgomery, C. A., Gonzalez, F. J., and Jaiswal, A. K. (2002) Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia, Cancer Res. 62, 3030-3036.
36. Kelloff, G. J., Sigman, C. C., and Greenwald, P. (1999) Cancer chemoprevention: Progress and promise, Eur. J. Cancer 35, 2031-2038.
37. Yang, S. H., Kim, J. S., Oh, T. J., Kim, M. S., Lee, S. W., Woo, S. K., Cho, H. S., Choi, Y. H., Kim, Y. H., Rha, S. Y., Chung, H. C., and An, S. W. (2003) Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray, Int. J. Oncol. 22, 741-750.
38. Kwak, M. K., Egner, P. A., Dolan, P. M., Ramos-Gomez, M., Groopman, J. D., Itoh, K., Yamamoto, M., and Kensler, T. W. (2001) Role of phase 2 enzyme induction in chemoprotection by dithiolethiones, Mutat. Res. 480-481, 305-315.
39. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., and Guittet, O. (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase, FEBS Lett. 421, 277-279.
40. Gu, X., Creasy, L., Kester, A., and Zeece, M. (1999) Capillary electrophoretic determination of resveratrol in wines, J. Agric. Food Chem. 47, 3223-3227.
41. Das, D. K., Sato, M., Ray, P. S., Maulik, G., Engelman, R. M., Bertelli, A. A., and Bertelli, A. (1999) Cardioprotection of red wine: Role of polyphenolic antioxidants, Drugs Exp. Clin. Res. 25, 115-120.
42. Graves, P. R., Kwiek, J. J., Fadden, P., Ray, R., Hardeman, K., Coley, A. M., Foley, M., and Haystead, T. A. (2002) Discovery of novel targets of quinoline drugs in the human purine binding proteome, Mol. Pharmacol. 62, 1364-1372.
43. Brehmer, D., Godl, K., Zech, B., Wissing, J., and Daub, H. (2004) Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors, Mol. Cell Proteomics 3, 490-500.
44. Nosjean, O., Ferro, M., Coge, F., Beauverger, P., Henlin, J. M., Lefoulon, F., Fauchere, J. L., Delagrange, P., Canet, E., and Boutin, J. A. (2000) Identification of the melatonin-binding site MT3 as the quinone reductase 2, J. Biol. Chem. 275, 31311-31317.
45. Kwiek, J. J., Haystead, T. A., and Rudolph, J. (2004) Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines, Biochemistry 43, 4538-4547.
46. Aziz, M. H., Kumar, R., and Ahmad, N. (2003) Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (review), Int. J. Oncol. 23, 17-28.
47. Caltagirone, S., Rossi, C., Poggi, A., Ranelletti, F. O., Natali, P. G., Brunetti, M., Aiello, F. B., and Piantelli, M. (2000) Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential, Int. J. Cancer 87, 595-600.
48. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., Scherer, B., and Sinclair, D. A. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature 425, 191-196.
49. Chen, S., Hwang, J., and Deng, P. S. (1993) Inhibition of NAD(P)H:quinone acceptor oxidoreductase by flavones: A structure-activity study, Arch. Biochem. Biophys. 302, 72-77.
50. Talalay, P. (1989) Mechanisms of induction of enzymes that protect against chemical carcinogenesis, Adv. Enzyme Regul. 28, 237-250.
51. Dhakshinamoorthy, S., and Jaiswal, A. K. (2001) Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase 1 gene, Oncogene 20, 3906-3917.
52. McMahon, M., Itoh, K., Yamamoto, M., Ghanas, S. A., Henderson, C. J., McLellan, L. I., Wolf, C. R., Cavin, C., and Hayes, J. D. (2001) The Cap′n′Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes, Cancer Res. 61, 3299-3307.
53. Kwak, M. K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., and Kensler, T. W. (2003) Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival, J. Biol. Chem. 278, 8135-8145.
54. Long, D. J., II, Waikel, R. L., Wang, X. J., Perlaky, L., Roop, D. R., and Jaiswal, A. K. (2000) NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo[a]pyrene-induced mouse skin carcinogenesis, Cancer Res. 60, 5913-5915.
55. Long, D. J., II, Waikel, R. L., Wang, X. J., Roop, D. R., and Jaiswal, A. K. (2001) NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin, J. Natl. Cancer Inst. 93, 1166-1170.
56. Henderson, C. J., Smith, A. G., Ure, J., Brown, K., Bacon, E. J., and Wolf, C. R. (1998) Increased skin tumorigenesis in mice lacking π class glutathione S-transferases, Proc. Natl. Acad. Sci. U.S.A. 95, 5275-5280.
57. Wolf, C. R., Campbell, S. J., Clark, A. J., Smith, A., Bishop, J. O., and Henderson, C. J. (1998) The use of transgenic animals to assess the role of metabolism in target organ toxicity, Arch. Toxicol. Suppl. 20, 443-453.
58. Clairmont, A., Sies, H., Ramachandran, S., Lear, J. T., Smith, A. G., Bowers, B., Jones, P. W., Fryer, A. A., and Strange, R. C. (1999) Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: Use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci, Carcinogenesis 20, 1235-1240.
59. Lafuente, M. J., Casterad, X., Trias, M., Ascaso, C., Molina, R., Ballesta, A., Zheng, S., Wiencke, J. K., and Lafuente, A. (2000) NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors, Carcinogenesis 21, 1813-1819.
60. Smith, M. T., Wang, Y., Skibola, C. F., Slater, D. J., Lo Nigro, L., Nowell, P. C., Lange, B. J., and Felix, C. A. (2002) Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children, Blood 100, 4590-4593.
61. Zhang, J. H., Li, Y., Wang, R., Sarbia, M., Guo, W., Wen, D. G., Wei, L. Z., Chen, Z. F., Kuang, G., Zhang, L. W., He, M., Wu, M. L., and Wang, S. J. (2003) The NAD(P)H:quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer, Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20, 544-546.
62. Zhang, J., Schulz, W. A., Li, Y., Wang, R., Zotz, R., Wen, D., Siegel, D., Ross, D., Gabbert, H. E., and Sarbia, M. (2003) Association of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population, Carcinogenesis 24, 905-909.
63. Zhang, J. H., Li, Y., Wang, R., Geddert, H., Guo, W., Wen, D. G., Chen, Z. F., Wei, L. Z., Kuang, G., He, M., Zhang, L. W., Wu, M. L., and Wang, S. J. (2003) NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China, World J. Gastroenterol. 9, 1390-1393.
64. Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M. I., Kobayashi, A., Yamamoto, M., Kensler, T. W., and Talalay, P. (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers, Proc. Natl. Acad. Sci. U.S.A. 101, 2040-2045.
65. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T., and Yamamoto, M. (2003) Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles, Genes Cells 8, 379-391.
66. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., and Yamamoto, M. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev. 13, 76-86.
67. Sekhar, K. R., Spitz, D. R., Harris, S., Nguyen, T. T., Meredith, M. J., Holt, J. T., Gius, D., Marnett, L. J., Summar, M. L., Freeman, M. L., and Guis, D. (2002) Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of γ-glutamylcysteine synthetase, Free Radical Biol. Med. 32, 650-662.
68. Sekhar, K. R., Yan, X. X., and Freeman, M. L. (2002) Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2, Oncogene 21, 6829-6834.
69. McMahon, M., Itoh, K., Yamamoto, M., and Hayes, J. D. (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression, J. Biol. Chem. 278, 21592-21600.